Main Article Content
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) possess the antipyretic, analgesic and anti-inflammatory effects. The main mechanism is the inhibition of cyclooxygenase activity. To study whether NSAIDs were ligands for Peroxisome Proliferator Activated Receptor α (PPARα), which might be another pathway to relief the inflammatory responses, H4IIEC3 cells could be used. In transactivation assay, H4IIEC3 cells were transfected by rat acyl CoA oxidase luciferase plasmid. The result showed that ibuprofen, ketoprofen, naproxen, salicylic acid, indomethacin and diclofenac but not for mefenamic acid was ligands for PPARα. S(+) ketoprofen and S (+)-ibuprofen were almost the same efficacy. They produced the maximal response 528.4 and 531.9% of control, respectively. The EC50 of S(+)-ketoprofen and S(+)ibuprofen were 1.905x10-5 and 2.11 X 10-5 M in PPARα activation. Lndomethacin produced small response. It produced the maximal response only 288.57% of control at 300 μM. The rank order for PPARα activation was S( + )-ketoprofen ≥ S( + )ibuprofen n> R(-)-ketoprofen ≥ R(-)-ibuprofen. Ibuprofen and ketoprofen isomers were tested for stereoselective activation to PPARα. The results showed that S-isomers of these drugs were more active than R-isomers. Using the biochemical assay to measure the hepatic peroxisomal fatty acyl CoA oxidase activity, they exhibited the same rank order, S-ketoprofen > S-ibuprofen > R-ibuprofen ≥ R-ketoprofen. To study the stereoselective effect on PP ARy activation, CV-1 cells were cotransfected with the PPARγ and the response element of rat adipocyte differentiation-luciferase plasmid. Contrast to PPARα activation, indomethacin was the most active drug for PPARγ activation, then R-ibuprofen and S-ibuprofen, respectively. Thus our result proposed that NSAIDs were ligands for both isoforms of PP AR and this might be an additional mechanism of them.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.